KOR TECNICOS FARMACEUTICOS SL
Company details
- Defunct NIF/CIF: B53598504
-
-
-
-
Address: Plaza del Pintor Sala, número 1 (ALCOY) See in map
-
-
Featured products:
More information on KOR TECNICOS FARMACEUTICOS SL
-
28/12/2005 | BORME act no.: 550349 | Register: ALICANTECeses/Dimisiones
-
28/12/2005 | BORME act no.: 550349 | Register: ALICANTENombramientos
-
28/12/2005 | BORME act no.: 550349 | Register: ALICANTEDisolución
-
27/08/2003 | BORME act no.: 261130 | Register: ALICANTEDepósito de cuentas anuales (agosto de 2003)
-
12/08/2002 | BORME act no.: 197045 | Register: ALICANTEDepósito de cuentas anuales (julio de 2002)
-
22/01/2002 | BORME act no.: 28925 | Register: ALICANTEConstitución
-
22/01/2002 | BORME act no.: 28925 | Register: ALICANTENombramientos
Other information
The CIF assigned to KOR TECNICOS FARMACEUTICOS SL is B53598504, and its business status is defunct. The company is engaged in an economic activity classified within the CNAE 8690 - Other health activities. In addition, its SIC identification - also defines it.
KOR TECNICOS FARMACEUTICOS SL employs a team of Between 10 and 49 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Alicante, and has 2 executive positions. Its most recent announcement in the Borme was published on 28/12/2005, while its last deposit of ordinary annual accounts is for the - fiscal year.
To access the contact information of KOR TECNICOS FARMACEUTICOS SL, such as the telephone number, postal address, or website, visit the Company Data module.
If you require more details about KOR TECNICOS FARMACEUTICOS SL, we invite you to consult one of our available financial reports, the company's Annual Accounts, or to check its payment incidents in the RAI delinquency file.
The financial, business, and legal information provided about KOR TECNICOS FARMACEUTICOS SL is extracted from official sources and is updated daily.
Do you want to know more about KOR TECNICOS FARMACEUTICOS SL??
Find out more about this company by consulting these reports: